During the past decade, Hospital da Senhora da Oliveira Guimaraes conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 14 clinical trials were completed, i.e. on average, 22.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 14 clinical trials were completed. i.e. 45.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital da Senhora da Oliveira Guimaraes" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Celgene" with 7 trials sponsored, "Shire" with 7 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Senhora da Oliveira Guimaraes" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Akcea Therapeutics" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hospital da Senhora da Oliveira Guimaraes" are "Ulcerative Colitis" (10 trials), "Crohn's Disease" (8 trials), "Crohn Disease" (6 trials), "Heart Failure" (5 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Hospital da Senhora da Oliveira Guimaraes" in a lesser frequency.

Most popular intervention types in "Hospital da Senhora da Oliveira Guimaraes" are "Drug" (53 trials), "Other" (14 trials), "Device" (8 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials), "GED-0301" (3 trials) and "Guselkumab Dose 1" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital da Senhora da Oliveira Guimaraes" are 65 trials for "All" genders.

Currently, there are NaN active trials in "Hospital da Senhora da Oliveira Guimaraes". undefined are not yet recruiting, 22 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Hospital da Senhora da Oliveira Guimaraes, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital da Senhora da Oliveira Guimaraes, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".